RWM
BMY icon

Rialto Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Rialto Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.8K Buy
690
+41
+6% +$2.39K 0.01% 300
2025
Q4 		$35K Buy
649
+31
+5% +$1.49K 0.01% 310
2025
Q3 		$27.9K Sell
618
-150
-20% -$7K 0.01% 314
2025
Q2 		$35.6K Sell
768
-701
-48% -$34.4K 0.01% 294
2025
Q1 		$89.6K Sell
1,469
-17
-1% -$991 0.03% 203
2024
Q4 		$84K Buy
+1,486
New +$83K 0.03% 214

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rialto Wealth Management's BMY Position: Q1 2026 in Review

Rialto Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 6.3% in Q1 2026, buying an estimated $2.39K and bringing the position to 690 shares worth $41.8K. The position accounts for 0.01% of the portfolio, ranked #300.

Rialto Wealth Management first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $89.6K in Q1 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Rialto Wealth Management held 690 shares of Bristol-Myers Squibb worth $41.8K as of Q1 2026.
  • Rialto Wealth Management bought 41 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.39K.
  • Bristol-Myers Squibb made up 0.01% of Rialto Wealth Management's portfolio in Q1 2026, its #300 holding.
  • Rialto Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Rialto Wealth Management's Bristol-Myers Squibb position peaked at $89.6K in Q1 2025.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.